ArticleMolecules (Basel, Switzerland)2026
Design, Synthesis and Anticancer Evaluation of Novel SO
Seungwan Kim, Lingayya Rajaka, Saegun Kim, In Jae Bang, Hyun Woo Lee, Minseo Choi, Jihyo Lee, Myunghwa Jung, Hyosik Woo, Sangil Han and 4 more
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Seungwan KimCollege of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Saegun KimCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Sookmyung Women's University, Seoul 04310, Republic of Korea.
In Jae BangInstitute of Pharmaceutical Science and Translational Research, Korea University, Sejong 30019, Republic of Korea.
Hyun Woo LeeCollege of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Minseo ChoiData Convergence Drug Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
Jihyo LeeCollege of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Myunghwa JungCollege of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Hyosik WooCollege of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Sangil HanDepartment of Innovative Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.ORCID 0000-0003-1562-3254 Hyun Jin KimData Convergence Drug Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.ORCID 0000-0001-6568-0658 Funding
Korea Environmental Industry and Technology Institute 202300230430Ministry of SMEs and Startups RS-2026-25613028National Research Foundation of Korea RS-2023-00235550National Research Foundation of Korea RS-2025-00557885National Research Foundation of Korea RS-2025-25399773
6 · The paper itselfAbstract
The weakly coordinating ketone group-directed C-H functionalizations of chromones, flavones, 1,4-naphthoquinones, (thio)xanthones, and acridones with ethenesulfonyl fluoride under rhodium(III) or ruthenium(II) catalysis are described. These protocols efficiently provide a range of chromone-based scaffolds and xanthone analogues bearing an SO
Indexed as
Antineoplastic AgentsDrug DesignKetonesA549 CellsCatalysisDrug Screening Assays, AntitumorHumansMolecular StructureRhodiumRutheniumStructure-Activity RelationshipXanthonesAntineoplastic AgentsKetonesRhodiumRutheniumXanthoneschromone derivativescytotoxic activityethenesulfonyl fluorideketone-directed C–H functionalizationxanthone derivatives
Identifiers
PMID42738753
PMCPMC13567039
What Socratic holds
Textmetadata
Read underepoch 390